|
|
Volumn 6, Issue 4, 2006, Pages 186-191
|
|
Rare diseases, orphan drugs, and orphaned patients.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HALOPERIDOL;
NEUROLEPTIC AGENT;
PIMOZIDE;
ARTICLE;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG MANUFACTURE;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LEGAL ASPECT;
PATIENT ADVOCACY;
RARE DISEASE;
UNITED STATES;
ANTIPSYCHOTIC AGENTS;
DRUG APPROVAL;
DRUG INDUSTRY;
HALOPERIDOL;
HUMANS;
LEGISLATION, DRUG;
ORPHAN DRUG PRODUCTION;
PATIENT ADVOCACY;
PIMOZIDE;
RARE DISEASES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 35748960343
PISSN: 15340384
EISSN: None
Source Type: Journal
DOI: 10.1124/mi.6.4.2 Document Type: Article |
|
Times cited : (11)
|
|
References (0)
|
